October 30, 2024

Lao Tribune

laotribune

December 22, 2021

    Hitachi Energy wins major contract for the first-of-its-kind sub-sea power transmission network in the MENA region advancing a sustainable energy future for Abu Dhabi

    ltadmin08 mins

    HVDC Light® will connect low-carbon power from the mainland grid to ADNOC’s production operations as a strategic project to enable a sustainable, flexible and secure power supply. Zurich, Switzerland, Dec. 22, 2021 (GLOBE NEWSWIRE) — Hitachi Energy today announced it has won a major order from Samsung C&T Corporation, one of the world’s largest engineering […]

    Read More

      Philips receives FDA De Novo Clearance for IVC Filter Removal Laser Sheath – CavaClear – with Breakthrough Device Designation

      ltadmin09 mins

      December 22, 2021 Philips IVC Filter Removal Laser Sheath – CavaClear – is intended to safely ablate tissue to remove embedded IVC filters CavaClear is a first-in-class FDA-cleared solution for advanced IVC filter removal It is estimated that in the United States more than one million patients with IVC filters would benefit from filter removal […]

      Read More

        Iveco Group N.V. announces publication of supplement to the prospectus dated November 11, 2021 relating to its listing on Euronext Milan

        ltadmin021 mins

        Corporate Communications ADVERTISEMENT. This announcement is an advertisement for the purposes of Regulation (EU) 2017/1129, as amended (the “Prospectus Regulation”) relating to the intention of Iveco Group N.V. (the “Company”) to proceed with the proposed first admission to listing and trading of all of the common shares of the Company on the regulated market of […]

        Read More

          HPTN Studies Inform FDA’s Approval of ViiV Healthcare’s Long-Acting Cabotegravir Injections for HIV Prevention

          ltadmin06 mins

          DURHAM, N.C., Dec. 21, 2021 (GLOBE NEWSWIRE) — Data from the HIV Prevention Trials Network (HPTN) studies HPTN 083 and HPTN 084 helped provide important information for yesterday’s decision by the U.S. Food and Drug Administration (FDA) to approve ViiV Healthcare’s long-acting cabotegravir (CAB-LA) injections for the prevention of HIV. Sponsored and co-funded by the […]

          Read More
          Back To Top